These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15476672)
21. Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells. Carelli S; Di Giulio AM; Paratore S; Bosari S; Gorio A J Cell Physiol; 2006 Aug; 208(2):354-62. PubMed ID: 16619240 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer. Sachdev D; Singh R; Fujita-Yamaguchi Y; Yee D Cancer Res; 2006 Feb; 66(4):2391-402. PubMed ID: 16489046 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Allen GW; Saba C; Armstrong EA; Huang SM; Benavente S; Ludwig DL; Hicklin DJ; Harari PM Cancer Res; 2007 Feb; 67(3):1155-62. PubMed ID: 17283150 [TBL] [Abstract][Full Text] [Related]
25. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Favelyukis S; Till JH; Hubbard SR; Miller WT Nat Struct Biol; 2001 Dec; 8(12):1058-63. PubMed ID: 11694888 [TBL] [Abstract][Full Text] [Related]
26. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). Jernberg-Wiklund H; Nilsson K Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. Moser C; Schachtschneider P; Lang SA; Gaumann A; Mori A; Zimmermann J; Schlitt HJ; Geissler EK; Stoeltzing O Eur J Cancer; 2008 Jul; 44(11):1577-86. PubMed ID: 18445520 [TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. Li S; Depetris RS; Barford D; Chernoff J; Hubbard SR Structure; 2005 Nov; 13(11):1643-51. PubMed ID: 16271887 [TBL] [Abstract][Full Text] [Related]
30. Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor. Cui SJ; Tewari M; Schneider T; Rubin R Alcohol Clin Exp Res; 1997 Sep; 21(6):1121-7. PubMed ID: 9309326 [TBL] [Abstract][Full Text] [Related]
31. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. Surmacz E; Bartucci M J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626 [TBL] [Abstract][Full Text] [Related]
33. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. Chisalita SI; Nitert MD; Arnqvist HJ Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559 [TBL] [Abstract][Full Text] [Related]
35. ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents. Steiner L; Blum G; Friedmann Y; Levitzki A Eur J Pharmacol; 2007 May; 562(1-2):1-11. PubMed ID: 17376430 [TBL] [Abstract][Full Text] [Related]
36. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines. Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691 [TBL] [Abstract][Full Text] [Related]
38. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
39. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells. Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560 [TBL] [Abstract][Full Text] [Related]
40. The tyrosine residue at 1250 of the insulin-like growth factor I receptor is required for ligand-mediated internalization. Miura M; Baserga R Biochem Biophys Res Commun; 1997 Oct; 239(1):182-5. PubMed ID: 9345292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]